3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer
NCT00326638 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72
Last updated 2020-04-17
Summary
In this study we are comparing two forms of radiotherapy. This study is being done because it is not clear at present time whether intensity modulated radiotherapy (IMRT) can reduce side effects of radiotherapy compared to standard radiotherapy (called 3D-Conformal Radiotherapy).
Conditions
Interventions
- RADIATION
-
Arm B: Helical Tomotherapy Intensity Modulated Radiotherapy
IMRT using Helical Tomotherapy\* 7800 cGY/39 Fractions once daily Monday to Friday for 8 weeks * Initial IMRT to Nodes/Prostate + Seminal Vesicles 4,600 cGy/23 * Boost IMRT to Prostate 3,200 cGy/16
- OTHER
-
Arm A: 3D-Conformal Radiation
3DCRT 7800 cGY/39 Fractions/ STD Technique\* once daily Monday to Friday for 8 weeks * Initial 4F 3DCRT to Nodes/ Prostate + Seminal Vesicles 4,600 cGy/23 * Boost 6 F 3DCRT to Prostate 3,200 cGy/16
Sponsors & Collaborators
-
Ottawa Hospital Research Institute
lead OTHER
Principal Investigators
-
Shawn Malone, MD · Ottawa Hospital Research Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-03-31
- Primary Completion
- 2015-01-31
- Completion
- 2020-06-30
Countries
- Canada
Study Locations
More Related Trials
-
Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate
NCT00548600 ·Status: COMPLETED ·Phase: PHASE3
-
Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer
NCT00122265 ·Status: TERMINATED
-
Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule
NCT02257827 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
NCT00331773 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
NCT00033631 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Hypofractionated Radiotherapy Boost to Conventionally Fractionated
NCT02300389 ·Status: COMPLETED ·Phase: NA
-
Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer
NCT00126165 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer
NCT03561220 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Stereotactic Radiotherapy for Oligometastatic Prostate Cancer
NCT02563691 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer
NCT03987386 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer
NCT05313815 ·Status: RECRUITING ·Phase: NA
-
Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)
NCT00890006 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer
NCT02107287 ·Status: COMPLETED ·Phase: NA
-
The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer
NCT00126802 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer
NCT01982786 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
NCT00258466 ·Status: WITHDRAWN ·Phase: PHASE3
-
Moderately Hypofractionated Radiotherapy for Prostate Cancer.
NCT03827616 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intensity Modulated Radiation Therapy for Prostate Cancer
NCT00214422 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer
NCT06835725 ·Status: RECRUITING ·Phase: PHASE2
-
Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer
NCT00946543 ·Status: UNKNOWN ·Phase: PHASE1
-
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer
NCT03274687 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)
NCT00967863 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hypo-fractionated Postoperative IMRT in Prostate Cancer
NCT03233672 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
NCT00002703 ·Status: COMPLETED ·Phase: PHASE3
-
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
NCT00969111 ·Status: RECRUITING ·Phase: NA